Aurisco Pharmaceutical Co Ltd (605116) — Free Cash Flow Generation Index
Aurisco Pharmaceutical Co Ltd (605116) has a Free Cash Flow Generation Index of -0.63x as of December 2024. Free cash flow of CN¥-207.87 Million represents -1% of operating cash flow (CN¥332.41 Million). See working capital position of Aurisco Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aurisco Pharmaceutical Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Aurisco Pharmaceutical Co Ltd across 8 annual periods. Explore Aurisco Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Aurisco Pharmaceutical Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Aurisco Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Aurisco Pharmaceutical Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | CN¥-207.87 Million | CN¥332.41 Million | CN¥540.28 Million | ▼ -400.9% |
| 2023 | 0.21x | CN¥80.13 Million | CN¥385.61 Million | CN¥305.48 Million | ▲ +169.4% |
| 2022 | -0.30x | CN¥-49.82 Million | CN¥166.41 Million | CN¥216.23 Million | ▼ -23.0% |
| 2021 | -0.24x | CN¥-49.04 Million | CN¥201.57 Million | CN¥250.61 Million | ▼ -193.7% |
| 2020 | 0.26x | CN¥55.68 Million | CN¥214.48 Million | CN¥158.80 Million | ▼ -56.5% |
| 2019 | 0.60x | CN¥107.43 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +319.5% |
| 2018 | 0.14x | CN¥15.63 Million | CN¥109.77 Million | CN¥94.14 Million | ▲ +48.4% |
| 2017 | 0.10x | CN¥11.31 Million | CN¥117.91 Million | CN¥106.60 Million | — |